217 related articles for article (PubMed ID: 25081058)
1. The catalytic region and PEST domain of PTPN18 distinctly regulate the HER2 phosphorylation and ubiquitination barcodes.
Wang HM; Xu YF; Ning SL; Yang DX; Li Y; Du YJ; Yang F; Zhang Y; Liang N; Yao W; Zhang LL; Gu LC; Gao CJ; Pang Q; Chen YX; Xiao KH; Ma R; Yu X; Sun JP
Cell Res; 2014 Sep; 24(9):1067-90. PubMed ID: 25081058
[TBL] [Abstract][Full Text] [Related]
2. "PEST control": regulation of molecular barcodes by tyrosine phosphatases.
Doody KM; Bottini N
Cell Res; 2014 Sep; 24(9):1027-8. PubMed ID: 25081059
[TBL] [Abstract][Full Text] [Related]
3. Molecular dynamics simulation studies on the specific regulation of PTPN18 to the HER2 phospho-peptides.
Tong M; Liu P; Sun W; Liu J; Fan N; Wang X; Zhang Z; Song X; Lv C; Wang Y
J Mol Recognit; 2021 Jul; 34(7):e2890. PubMed ID: 33620127
[TBL] [Abstract][Full Text] [Related]
4. Switching of the substrate specificity of protein tyrosine phosphatase N12 by cyclin-dependent kinase 2 phosphorylation orchestrating 2 oncogenic pathways.
Li H; Yang D; Ning S; Xu Y; Yang F; Yin R; Feng T; Han S; Guo L; Zhang P; Qu W; Guo R; Song C; Xiao P; Zhou C; Xu Z; Sun JP; Yu X
FASEB J; 2018 Jan; 32(1):73-82. PubMed ID: 28842430
[TBL] [Abstract][Full Text] [Related]
5. A specific amino acid context in EGFR and HER2 phosphorylation sites enables selective binding to the active site of Src homology phosphatase 2 (SHP2).
Hartman Z; Geldenhuys WJ; Agazie YM
J Biol Chem; 2020 Mar; 295(11):3563-3575. PubMed ID: 32024694
[TBL] [Abstract][Full Text] [Related]
6. PEST motif serine and tyrosine phosphorylation controls vascular endothelial growth factor receptor 2 stability and downregulation.
Meyer RD; Srinivasan S; Singh AJ; Mahoney JE; Gharahassanlou KR; Rahimi N
Mol Cell Biol; 2011 May; 31(10):2010-25. PubMed ID: 21402774
[TBL] [Abstract][Full Text] [Related]
7. Phospho-PTM proteomic discovery of novel EPO- modulated kinases and phosphatases, including PTPN18 as a positive regulator of EPOR/JAK2 Signaling.
Held MA; Greenfest-Allen E; Su S; Stoeckert CJ; Stokes MP; Wojchowski DM
Cell Signal; 2020 May; 69():109554. PubMed ID: 32027948
[TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor cytoplasmic domain affects ErbB protein degradation by the lysosomal and ubiquitin-proteasome pathway in human cancer cells.
Glogowska A; Stetefeld J; Weber E; Ghavami S; Hoang-Vu C; Klonisch T
Neoplasia; 2012 May; 14(5):396-409. PubMed ID: 22745586
[TBL] [Abstract][Full Text] [Related]
9. β-TrCP-mediated ubiquitination and degradation of liver-enriched transcription factor CREB-H.
Cheng Y; Gao WW; Tang HM; Deng JJ; Wong CM; Chan CP; Jin DY
Sci Rep; 2016 Mar; 6():23938. PubMed ID: 27029215
[TBL] [Abstract][Full Text] [Related]
10. Crystal Structure and Substrate Specificity of PTPN12.
Li H; Yang F; Liu C; Xiao P; Xu Y; Liang Z; Liu C; Wang H; Wang W; Zheng W; Zhang W; Ma X; He D; Song X; Cui F; Xu Z; Yi F; Sun JP; Yu X
Cell Rep; 2016 May; 15(6):1345-58. PubMed ID: 27134172
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanism of ERK dephosphorylation by striatal-enriched protein tyrosine phosphatase.
Li R; Xie DD; Dong JH; Li H; Li KS; Su J; Chen LZ; Xu YF; Wang HM; Gong Z; Cui GY; Yu X; Wang K; Yao W; Xin T; Li MY; Xiao KH; An XF; Huo Y; Xu ZG; Sun JP; Pang Q
J Neurochem; 2014 Jan; 128(2):315-329. PubMed ID: 24117863
[TBL] [Abstract][Full Text] [Related]
12. Nuclear import of PTPN18 inhibits breast cancer metastasis mediated by MVP and importin β2.
Wang T; Ba X; Zhang X; Zhang N; Wang G; Bai B; Li T; Zhao J; Zhao Y; Yu Y; Wang B
Cell Death Dis; 2022 Aug; 13(8):720. PubMed ID: 35982039
[TBL] [Abstract][Full Text] [Related]
13. Dual degradation signals destruct GLI1: AMPK inhibits GLI1 through β-TrCP-mediated proteasome degradation.
Zhang R; Huang SY; Ka-Wai Li K; Li YH; Hsu WH; Zhang GJ; Chang CJ; Yang JY
Oncotarget; 2017 Jul; 8(30):49869-49881. PubMed ID: 28562331
[TBL] [Abstract][Full Text] [Related]
14. Structural basis of substrate recognition by hematopoietic tyrosine phosphatase.
Critton DA; Tortajada A; Stetson G; Peti W; Page R
Biochemistry; 2008 Dec; 47(50):13336-45. PubMed ID: 19053285
[TBL] [Abstract][Full Text] [Related]
15. Blockage of conformational changes of heat shock protein gp96 on cell membrane by a α-helix peptide inhibits HER2 dimerization and signaling in breast cancer.
Li X; Wang B; Liu W; Gui M; Peng Z; Meng S
PLoS One; 2015; 10(4):e0124647. PubMed ID: 25898135
[TBL] [Abstract][Full Text] [Related]
16. PTPN12 controls PTEN and the AKT signalling to FAK and HER2 in migrating ovarian cancer cells.
Villa-Moruzzi E
Mol Cell Biochem; 2013 Mar; 375(1-2):151-7. PubMed ID: 23212450
[TBL] [Abstract][Full Text] [Related]
17. HER2 stabilizes EGFR and itself by altering autophosphorylation patterns in a manner that overcomes regulatory mechanisms and promotes proliferative and transformation signaling.
Hartman Z; Zhao H; Agazie YM
Oncogene; 2013 Aug; 32(35):4169-80. PubMed ID: 23027125
[TBL] [Abstract][Full Text] [Related]
18. Structure of a beta-TrCP1-Skp1-beta-catenin complex: destruction motif binding and lysine specificity of the SCF(beta-TrCP1) ubiquitin ligase.
Wu G; Xu G; Schulman BA; Jeffrey PD; Harper JW; Pavletich NP
Mol Cell; 2003 Jun; 11(6):1445-56. PubMed ID: 12820959
[TBL] [Abstract][Full Text] [Related]
19. Negative regulation of HER2 signaling by the PEST-type protein-tyrosine phosphatase BDP1.
Gensler M; Buschbeck M; Ullrich A
J Biol Chem; 2004 Mar; 279(13):12110-6. PubMed ID: 14660651
[TBL] [Abstract][Full Text] [Related]
20. Distinct phosphotyrosine-dependent functions of the ShcA adaptor protein are required for transforming growth factor β (TGFβ)-induced breast cancer cell migration, invasion, and metastasis.
Northey JJ; Dong Z; Ngan E; Kaplan A; Hardy WR; Pawson T; Siegel PM
J Biol Chem; 2013 Feb; 288(7):5210-22. PubMed ID: 23277357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
